Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for AORT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -1.266M
March 31, 2026 1.154M
December 31, 2025 21.31M
September 30, 2025 20.51M
June 30, 2025 15.01M
March 31, 2025 -16.95M
December 31, 2024 10.14M
September 30, 2024 11.46M
June 30, 2024 6.135M
March 31, 2024 -5.493M
December 31, 2023 10.59M
September 30, 2023 7.232M
June 30, 2023 6.909M
March 31, 2023 -6.154M
December 31, 2022 -0.217M
September 30, 2022 3.976M
June 30, 2022 -8.314M
March 31, 2022 -0.598M
December 31, 2021 0.716M
September 30, 2021 -2.909M
June 30, 2021 0.428M
March 31, 2021 -3.039M
December 31, 2020 5.45M
September 30, 2020 7.679M
June 30, 2020 -3.395M
Date Value
March 31, 2020 2.635M
December 31, 2019 1.06M
September 30, 2019 12.86M
June 30, 2019 0.746M
March 31, 2019 1.161M
December 31, 2018 10.52M
September 30, 2018 8.32M
June 30, 2018 0.767M
March 31, 2018 -9.727M
December 31, 2017 5.977M
September 30, 2017 2.804M
June 30, 2017 -1.847M
March 31, 2017 3.869M
December 31, 2016 5.045M
September 30, 2016 8.836M
June 30, 2016 4.428M
March 31, 2016 1.41M
December 31, 2015 1.415M
September 30, 2015 4.833M
June 30, 2015 3.896M
March 31, 2015 1.298M
December 31, 2014 4.785M
September 30, 2014 2.504M
June 30, 2014 2.867M
March 31, 2014 -2.038M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Alphatec Holdings, Inc. 20.51M
Globus Medical, Inc. 209.74M
Glaukos Corp. 14.82M
TransMedics Group, Inc. 17.31M
PROCEPT BioRobotics Corp. -19.25M